Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells
Abstract Background SARS-CoV-2, which has brought a huge negative impact on the world since the end of 2019, is reported to invade cells using the spike (S) protein to bind to angiotensin-converting enzyme II (ACE2) receptors on human cells while the transmembrane protease serine 2 (TMPRSS2) is the...
Main Authors: | Jinfeng Peng, Jiwei Sun, Jiajia Zhao, Xuliang Deng, Fengyuan Guo, Lili Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-021-03037-4 |
Similar Items
-
ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment
by: Akçahan GEPDİREMEN, et al.
Published: (2020-12-01) -
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
by: Yuan Hou, et al.
Published: (2020-07-01) -
Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
by: Alexandra Lindsey Zune Djomkam, et al.
Published: (2020-08-01) -
GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies
by: Ching-Yuan Wu, et al.
Published: (2020-12-01) -
Antibody Engineering Towards Enhancement of Spike Protein SARS-COV-2 -m396 Binding Affinity
by: Fateme Sefid, et al.
Published: (2021-01-01)